Nanoscopic and photonic ultrastructural characterization of two distinct insulin amyloid states

International Journal of Molecular Sciences

Volumn 13, Issue 2, 2012, Pages 1461-1480

  Psonka Antonczyk, Katarzyna Maria ^a   Duboisset, Julien ^a   Stokke, Bjørn Torger ^a   Zako, Tamotsu ^b   Kobayashi, Takahiro ^b   Maeda, Mizuo ^b   Nyström, Sofie ^c   Mason, Jeff ^c   Hammarström, Per ^c   Nilsson, K Peter R ^c   Lindgren, Mikael ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b RIKEN   (Japan)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Amyloid proteins; Fluorescence assay; Oligomeric amyloid state; Oligothiophene fluorescence stains; Pre fibrillar intermediate state; TIRFM AFM

Indexed keywords

AMYLOID; ARGININE; HISTIDINE; INSULIN AMYLOID; LUMINESCENT CONJUGATED OLIGOTHIOPHENE; LYSINE; THIOPHENE; UNCLASSIFIED DRUG; INSULIN; PROTEIN AGGREGATE; THIOPHENE DERIVATIVE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; MOLECULAR IMAGING; MOLECULAR PROBE; PH; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; SURFACE PROPERTY; TOTAL INTERNAL REFLECTION FLUORESCENCE MICROSCOPY; ULTRASTRUCTURE; ZETA POTENTIAL; CHEMICAL PHENOMENA; CHEMISTRY; HUMAN; SPECTROFLUOROMETRY;

AMYLOID; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INSULIN; MICROSCOPY, ATOMIC FORCE; PROTEIN AGGREGATES; SPECTROMETRY, FLUORESCENCE; THIOPHENES;

EID: 84863251372     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13021461     Document Type: Article

References (47)

1. Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75, 333-366.
2. Sipe, J.D.; Cohen, A.S. Review: History of the amyolid fibril. J. Struct. Biol. 2000, 130, 88-98.
3. Selkoe, D.J. The molecular pathology of Alzheimer's disease. Neuron 1991, 6, 487-498.
4. Westermark, P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 2005, 272, 5942-5949.
5. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C.M.; Stefani, M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416, 507-511.
6. Wiréhn, J.; Carlsson, K.; Herland, A.; Persson, E.; Carlsson, U.; Svensson, M.; Hammarstrom, P. Activity, folding, misfolding, and aggregation in vitro of the naturally occurring human tissue factor mutant R200W. Biochemistry 2005, 44, 6755-6763.
7. Dobson, C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329-332.
8. Ross, C.A.; Poirier, M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10, S10-S17.
9. Uversky, V.N.; Fink, A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 2004, 1698, 131-153.
10. Sorgjerd, K.; Klingstedt, T.; Lindgren, M.; Kågedal, K.; Hammarström, P. Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture. Biochem. Biophys. Res. Commun. 2008, 377, 1072-1078.
11. Gharibyan, A.L.; Zamotin, V.; Yanamandra, K.; Moskaleva, O.S.; Margulis, B.A.; Kostanyan, I.A.; Morozova-Roche, L.A. Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. J. Mol. Biol. 2007, 365, 1337-1349.
12. Bamberger, M.E.; Harris, M.E.; McDonald, D.R.; Husemann, J.; Landreth, G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 2003, 23, 2665-2674.
13. Vestergaard, B.; Groenning, M.; Roessle, M.; Kastrup, J.S.; van de Weert, M.; Flink, J.M.; Frokjaer, S.; Gajhede, M.; Svergun, D.I. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol. 2007, 5, e134.
14. Petkova, A.T.; Ishii, Y.; Balbach, J.J.; Antzutkin, O.N.; Leapman, R.D.; Delaglio, F.; Tycko, R. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA 2002, 99, 16742-16747.
15. Antzutkin, O.N.; Balbach, J.J.; Tycko, R. Site-specific identification of non-β-strand conformations in Alzheimer's b-amyloid fibrils by solid-state NMR. Biophys. J. 2003, 84, 3326-3335.
16. Naiki, H.; Higuchi, K.; Hosokawa, M.; Takeda, T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal. Biochem. 1989, 177, 244-249.
17. Klunk, W.E.; Pettergrew, J.W.; Abraham, D.J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem. 1995, 37, 1273-1281.
18. Lindgren, M.; Sorgjerd, K.; Hammarstrom, P. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys. J. 2005, 88, 4200-4212.
19. Alizadeh-Pasdar, N.; Li-Chan, E.C.Y. Comparison of protein surface hydrophobicity measured at various pH values using three different fluorescent probes. J. Agric. Food Chem. 2000, 48, 328-334.
20. Wierenga P.A.; Meinders, M.B.J.; Egmond, M.R.; Voragen, A.G.J. Protein exposed hydrophobicity reduces the kinetic barrier for adsorption of ovalbumin to the air-water interface. Langmuir 2003, 19, 8964-8970.
21. Luk, K.C.; Hyde, E.G.; Trojanowski, J.Q.; Lee, V.M.-Y. Sensitive fluorescence polarization technique for rapid screening of α-synuclein oligomerization/fibrillization inhibitors. Biochemistry 2007, 46, 12522-12529.
22. Orte, A.; Birkett, N.R.; Clarke, R.W.; Devlin, G.L.; Dobson, C.M.; Klenerman, D. Direct characterization of amyloidogenic oligomers by single-molecule detection. Proc. Natl. Acad. Sci. USA 2008, 105, 14424-14429.
23. Nilsson, K.P.R. Small organic probes as amyloid specific ligands-Past and recent molecular scaffolds. FEBS Lett. 2009, 583, 2593-2599.
24. Nilsson, K.P.R.; Olsson, J.D.M.; Stabo-Eeg, F.; Lindgren, M.; Konradsson, P.; Inganas, O. Chiral recognition of a synthetic peptide using enantiomeric conjugated polyelectrolytes and optical spectroscopy. Macromolecules 2005, 38, 6813-6821.
25. Åslund, A.; Herland, A.; Hammarström, P.; Nilsson, K.P.R.; Jonsson, B.H.; Konradsson, P. Studies of luminescent conjugated polythiophene derivatives: Enhanced spectral discrimination of protein conformational states. Bioconjug. Chem. 2007, 18, 1860-1868.
26. Åslund, A.; Nilsson, K.P.R.; Konradsson, P. Fluorescent oligo and poly-thiophenes and their utilization for recording biological events of diverse origin-when organic chemistry meets biology. J. Chem. Biol. 2009, 2, 161-175.
27. Sigurdson, C.J.; Nilsson, K.P.R.; Hornemann, S.; Manco, G.; Polymenidou, M.; Schwarz, P.; Leclerc, M.; Hammarström, P.; Wüthrich, K.; Aguzzi, A. Prion strain discrimination using luminescent conjugated polymers. Nat. Methods 2007, 12, 1023-1030.
28. Sigurdson, C.J.; Nilsson, K.P.R.; Hornemann, S.; Heikenwalder, M.; Manco, G.; Schwarz, P.; Ott, D.; Rülicke, T.; Liberski, P.P.; Julius, C. et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc. Natl. Acad. Sci. USA 2009, 106, 304-309.
29. Nilsson, K.P.R.; Åslund, A.; Berg, I.; Nyström, S.; Konradsson, P.; Herland, A.; Inganäs, O.; Stabo-Eeg, F.; Lindgren, M.; Westermark, G.T. et al. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem. Biol. 2007, 2, 553-560.
30. Nilsson, K.P.R.; Hammarström, P.; Ahlgren, F.; Herland, A.; Schnell, E.A.; Lindgren, M.; Westermark, G.T.; Inganäs, O. Conjugated polyelectrolytes-conformation-sensitive optical probes for staining and characterization of amyloid deposits. ChemBioChem 2006, 7, 1096-1104.
31. Stabo-Eeg, F.; Lindgren, M.; Nilsson, K.P.R.; Inganäs, O.; Hammarström, P. Quantum efficiency and two-photon absorption cross-section of conjugated polyelectrolytes used for protein conformation measurements with applications on amyloid structures. Chem. Phys. 2007, 336, 121-126.
32. Åslund, A.; Sigurdson, C.J.; Klingstedt, T.; Grathwohl, S.; Bolmont, T.; Dickstein, D.L.; Glimsdal, E.; Prokop, S.; Lindgren, M.; Konradsson, P. et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem. Biol. 2009, 4, 673-684.
33. Zako, T.; Sakono, M.; Hashimoto, N.; Ihara, M.; Maeda, M. Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils. Biophys. J. 2009, 96, 3331-3340.
34. Klingstedt, T.; Åslund, A.; Simon, R.A.; Johansson, L.B.G.; Mason, J.J.; Nyström, S.; Hammarström, P.; Nilsson, K.P.R. Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org. Biomol. Chem. 2011, 9, 8356-8370.
35. Kumar, S.; Nussinov, R. Close-range electrostatic interactions in proteins. ChemBioChem 2002, 3, 604-617.
36. Horovitz, A.; Serrano, L.; Avron, B.; Bycroft, M.; Fersht, A.R. Strength and co-operativity of contributions of surface salt bridges to protein stability. J. Mol. Biol. 1990, 216, 1031-1044.
37. Yang, H. Fung, S.Y. Pritzker, M. Chen, P. Surface-assisted assembly of an ionic-complementary peptide: Controllable growth of nanofibers. J. Am. Chem. Soc. 2007, 129, 12200-122010.
38. Sletmoen, M.; Skjåk-Bræk, G.; Stokke, B.T. Single-molecular pair unbinding studies of mannuronan C-5 epimerase AlgE4 and its polymer substrate. Biomacromolecules 2004, 5, 1288-1295.
39. Lindgren, M.; Hammarström, P. Amyloid oligomers: Spectroscopic characterization of amyloidogenic protein states. FEBS J. 2010, 277, 1380-1388.
40. Fukuma, T.; Mostaert, A.S.; Serpell, L.C.; Jarvis, S.P. Revealing molecular-level surface structure of amyloid fibrils in liquid by means of frequency modulation atomic force microscopy. Nanotechnology 2008, 19, 384010.
41. Blackley, H.K.L.; Sanders, G.H.W.; Davies, M.C.; Roberts, C.J.; Tendler, S.J.B.; Wilkinson, M.J. In situ atomic force microscopystudy of β-amyloid fibrillization. J. Mol. Biol. 2000, 298, 833-840.
42. Adamcik, J.; Jung, J.-M.; Flakowski, J.; De Los Rios, P.; Dietler, G.; Mezzenge, R. Understanding amyloid aggregation by statistical analysis of atomic force microscopy images. Nat. Nanotechnol. 2010, 5, 423-428.
43. Sedman, V.L.; Adler-Abramovich, L.; Allen, S.; Gazit, E.; Tendler, S.J.B. Direct observation of the release of phenylalanine from diphenylalanine nanotubes. J. Am. Chem. Soc. 2006, 128, 6903-6908.
44. Jimenez, J.L.; Nettleton, E.J.; Bouchard, M.; Robinson, C.V.; Dobson, C.M.; Saibil, H.R. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. USA 2002, 99, 9196-9201.
45. Zako, T.; Sakono, M.; Kobayashi, T.; Sörgerd, K.; Nilsson, K.P.R.; Hammarström, P.; Lindgren, M.; Maeda, M. Cell Interaction study of amyloid by using luminescent conjugated polythiophene: Implication that amyloid cytotoxicity is correlated with prolonged cellular binding. Chem Bio Chem 2012, doi:10.1002/cbic.201100467.
46. Brange, J.; Andersen, L.; Laursen, E.D.; Meyn, G.; Rasmussen, E. Toward understanding insulin fibrillation. J. Pharmac. Sci. 1997, 86, 517-525.
47. Nielsen, L.; Frokjaer, S.; Carpenter, J.F.; Brange, J. Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy. J. Pharmac. Sci. 2001, 90, 29-37.